Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study.

NCT04352855 · clinicaltrials.gov ↗

UNKNOWN

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Ventilator Associated Pneumonia
Antibiotic Resistant Infection

Interventions

DRUG: Ceftolozane/tazobactam

Sponsor

Semmelweis University